TY - JOUR
T1 - Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era
AU - Borgaonkar, Sanket
AU - Hahn, Joshua
AU - Daher, Marilyne
AU - Kayani, Waleed
AU - Jneid, Hani
N1 - Publisher Copyright:
© 2021, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
PY - 2021/6
Y1 - 2021/6
N2 - Purpose of Review: To identify and address the challenges associated with the care of ACS patients during the coronavirus 2019 pandemic. Recent Findings: The COVID-19 pandemic has had a considerable global impact with over 2.0 million deaths worldwide so far. There has been considerable evidence suggesting that COVID-19 increases the risk of acute coronary syndromes (ACS). Summary: We propose characterizing ACS patients into 3 distinct categories to better assist in appropriate triage and management: critically ill patients, non-critically ill ST elevation myocardial infarction (STEMI) patients, and non-critically ill non-ST elevation myocardial infarction (NSTEMI)/unstable angina (UA) patients. We thoroughly review treatments strategies, management considerations, and current consensus statements for the care of COVID-19 patients with ACS. As we continue to gain more experience with management of COVID-19 in ACS patients and as health-care workers and patients continue to get vaccinated, we must continue to adapt our strategies to treat this high-risk group of patients.
AB - Purpose of Review: To identify and address the challenges associated with the care of ACS patients during the coronavirus 2019 pandemic. Recent Findings: The COVID-19 pandemic has had a considerable global impact with over 2.0 million deaths worldwide so far. There has been considerable evidence suggesting that COVID-19 increases the risk of acute coronary syndromes (ACS). Summary: We propose characterizing ACS patients into 3 distinct categories to better assist in appropriate triage and management: critically ill patients, non-critically ill ST elevation myocardial infarction (STEMI) patients, and non-critically ill non-ST elevation myocardial infarction (NSTEMI)/unstable angina (UA) patients. We thoroughly review treatments strategies, management considerations, and current consensus statements for the care of COVID-19 patients with ACS. As we continue to gain more experience with management of COVID-19 in ACS patients and as health-care workers and patients continue to get vaccinated, we must continue to adapt our strategies to treat this high-risk group of patients.
KW - Acute coronary syndrome
KW - COVID-19
KW - Cardiac catheterization
KW - Health personnel
KW - Personal protective equipment
KW - ST elevation myocardial infarction
UR - http://www.scopus.com/inward/record.url?scp=85105528769&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105528769&partnerID=8YFLogxK
U2 - 10.1007/s11886-021-01501-7
DO - 10.1007/s11886-021-01501-7
M3 - Review article
C2 - 33961122
AN - SCOPUS:85105528769
SN - 1523-3782
VL - 23
JO - Current Cardiology Reports
JF - Current Cardiology Reports
IS - 6
M1 - 69
ER -